Home » Aaron F. Barkoff
Aaron F. Barkoff
Aaron F. Barkoff is a patent attorney at McDonnell Boehnen Hulbert & Berghoff LLP, a law firm in Chicago. Aaron specializes in representing pharmaceutical and biotechnology companies. He is especially interested in issues that overlap between patent law and food & drug law, and he authors a weblog, Orange Book Blog, that reports on those issues.
Aaron F. Barkoff's Latest Articles
Page 1 of 3
- Eisai Victorious Over Teva and Dr. Reddy’s in Aciphex Compound Patent Case
- Merck Victorious over Apotex in Fosamax Counterclaims Case
- Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal
- Roche and Allergan Victorious Over Apotex in Acular LS Dispute
- Barr and Mylan Invalidate Boehringer Ingelheim's Patent on Mirapex
-
Teva Granted Final Approval of Risperidone ANDA; Launches with 180-Day Exclusivity
on Jul 02, 2008 about TEVA
-
FDA Denies King Pharma's Citizen Petition on Altace; Approves Ramipril ANDAs
on Jun 26, 2008 about KG
- Mylan Prevails Over AstraZeneca in Appeal of Prilosec Case
-
King Pharmaceuticals Files Citizen Petition Relating to New Altace Patent
on May 27, 2008 about KG
- Apotex Sues FDA to Recover Its 180-Day Exclusivity on Generic Plavix
- Impax's Declaratory Judgment Complaint in ANDA Case Against Medicis Dismissed
- Validity of Takeda's Prevacid Patents Upheld; Teva's Obviousness Arguments Rejected
- Court Affirms Decision Protecting Ortho-McNeil's Topamax Against Mylan's Generic
- Federal Circuit Rules in Favor of Forest in Dispute with Caraco over Lexapro
- Eisai Wins Preliminary Injunction Against Teva's Generic Altheimer's Drug
- Court Sides with Amgen in European-Produced EPO Dispute with Roche
- Court Upholds P&G's Actonel Patent; Rejects Teva's Obviousness Arguments
- Pfizer's Latest-Expiring Patent on Celebrex Invalidated for Double Patenting
- Barr Labs Prevails Over Bayer in Yasmin Case
- Teva Trying to Assert Its Rights
-
Pfizer Victorious over Ranbaxy in Caduet Patent Litigation
on Dec 12, 2007 about PFE
- Teva's Nonenablement Argument Rejected as Court Finds Pfizer's Accupril Patent Valid
-
Court Dismisses Apotex's Cosopt Exclusivity Counterclaims Against Merck
on Nov 29, 2007 about MRK
- Bayer Prevails Over Dr. Reddy's in Avelox Case
- Invalidity of Par Pharma's Patents on Megestrol Acetate Formulations Affirmed by Federal Circuit Court
- Pfizer Wins Appeal in Neurontin Case
- Teva's Generic Famir Victory Overshadowed by Novartis' Emergency Injunction
- Aventis' Altace Patent Invalidated by Circuit Court
- Federal Circuit Court Denies Teva's Appeal of Forest Labs' Lexapro Patent
-
Pfizer: Lipitor Reissue Patent Application Rejected
on Aug 20, 2007 about PFE
-
Court Denies Validity of AstraZeneca's Toprol-XL Patent
on Jul 26, 2007 about AZN
- Merck's Formulation Patent on Pepcid Complete Invalidated by District Court
Loading...
Symbols:
Authors:
July 24, 2008
| Last Updated
17:30
ET
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Trading Center
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Tools & Widgets
- Stock Market Toolbar
- Stock Search Add-on
- Power Search
- Email Alerts
- Live Feeds (RSS)
- Legal
- Terms of Use
- Privacy
- Copyright
- Advertise
Want to talk to our community?
Got something interesting to say?
- Advertise with Us
Latest Commentson Aaron F. Barkoff's Articles